C.M. Laumont et al., “Noncoding regions are the main source of targetable tumor-specific antigens,” Sci Transl Med, 10:eaau5516, 2019. In pursuit of safe and effective cancer therapies, researchers ...

The global CD Antigen Cancer Therapy Market is valued at USD 27.5 Billion in 2024 and is projected to reach a value of USD 54 ...

Adoptive transfer of antibodies to pancreatic cancer surface antigens such ... variable fragment antibody chain specific for a pancreas cancer-associated antigen fused to a transmembrane signaling ...

Initially designed for hematological malignancies, CAR-T therapy is now being expanded to target solid tumors using specialized CAR-T cells that attack specific antigens. Ongoing clinical trials are ...

Enara Bio has raised $32.5m in a Series B financing round to advance its platform shining a light on cancer-specific antigens ... present novel peptide antigens on their surface, coded by these ...

In this case, the tumor on the right was irradiated; the left one was not ... Ruggiero A, Holland JP, Hudolin T, Shenker L, Koulova, A, Bander N, Lewis JS, Grimm J (2011) Targeting the internal ...

Researchers continuously work to develop immunotherapy treatments that help the immune system recognize and attack specific protein targets on cancer cells, also known as tumor antigens ...

Inc., Rahway, N.J., USA) to identify Cryptigen™ tumor-specific antigens (TSAs) in an undisclosed solid tumor. Cryptigen™ TSAs are shared, non-mutated, aberrantly expressed antigens that are ...